Abstract
Ubiquitin-specific protease 15 (USP15) regulates important cellular processes, including transforming growth factor β (TGF-β) signaling, mitophagy, mRNA processing, and innate immune responses; however, structural information on USP15's catalytic domain is currently unavailable. Here, we determined crystal structures of the USP15 catalytic core domain, revealing a canonical USP fold, including a finger, palm, and thumb region. Unlike for the structure of paralog USP4, the catalytic triad is in an inactive configuration with the catalytic cysteine ∼10 Å apart from the catalytic histidine. This conformation is atypical, and a similar misaligned catalytic triad has so far been observed only for USP7, although USP15 and USP7 are differently regulated. Moreover, we found that the active-site loops are flexible, resulting in a largely open ubiquitin tail–binding channel. Comparison of the USP15 and USP4 structures points to a possible activation mechanism. Sequence differences between these two USPs mainly map to the S1′ region likely to confer specificity, whereas the S1 ubiquitin–binding pocket is highly conserved. Isothermal titration calorimetry monoubiquitin- and linear diubiquitin-binding experiments showed significant differences in their thermodynamic profiles, with USP15 displaying a lower affinity for monoubiquitin than USP4. Moreover, we report that USP15 is weakly inhibited by the antineoplastic agent mitoxantrone in vitro. A USP15–mitoxantrone complex structure disclosed that the anthracenedione interacts with the S1′ binding site. Our results reveal first insights into USP15's catalytic domain structure, conformational changes, differences between paralogs, and small-molecule interactions and establish a framework for cellular probe and inhibitor development.
Highlights
Ubiquitin-specific protease 15 (USP15) regulates important cellular processes, including transforming growth factor  (TGF-) signaling, mitophagy, mRNA processing, and innate immune responses; structural information on USP15’s catalytic domain is currently unavailable
To determine the structure of the USP15 catalytic domain, we designed a construct spanning the catalytic core region (USP15-D1D2; Fig. 1A), with the insert harboring a predicted UBL domain replaced by a short linker (based on the USP8 structure, PDB entry 2GFO [27])
USP15-D1D2 was subjected to sparse matrix crystallization screening, and crystals were obtained in conditions using 0.1 M Tris-Cl, pH 8.5, 20% PEG 2000
Summary
Ubiquitin-specific protease 15 (USP15) regulates important cellular processes, including transforming growth factor  (TGF-) signaling, mitophagy, mRNA processing, and innate immune responses; structural information on USP15’s catalytic domain is currently unavailable. Ase domain that harbors a ϳ300-amino acid insertion predicted to contain a second UBL domain (Fig. 1A) These ancillary domains affect the catalytic function in different ways, whereby they regulate the catalytic activity of USP4 [24], whereas USP11’s activity is not significantly modulated by their presence using a model substrate [17, 24]. We determined the structure of a USP15– mitoxantrone complex, a Food and Drug Administration– approved antineoplastic drug [25], which has multiple cellular targets [26], including USP11 [25], that shows a novel binding mode for a USP ligand Together, these findings allow novel insights into the USP15 structure, substrate recognition, and differences between close USP paralogs, and they provide tools for structure-based drug design
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.